Page 18 - Foster Mitchell News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Investegate announcements from Medica Group PLC, Appointment of Liberum as Joint Corporate Broker

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional bod...

    Beximco Pharmaceuticals Limited ("Beximco Pharma" or "the Company", or "the Group"; AIM Symbol: BXP, LEI No.: 213800IMBBD6TIOQGB56), the fast-growing manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, announces it has entered into a binding commitment with Sanofi group regarding the acquisition of a majority stake in Sanofi Bangladesh Limited ("Sanofi Bangladesh") for a base-price consideration of circa £35.5 million, to be adjusted as set out below (the " Proposed Transaction"). The Proposed Transaction i...

Tel: +44 (0)20 3727 1000   About Beximco Pharmaceuticals Limited Beximco Pharma is a leading manufacturer and exporter of medicines based in Bangladesh. Since its inception in 1976, the Company remains committed to health and wellbeing of people across all the continents by providing access to contemporary medicines. Company's broad portfolio of generics encompasses diverse delivery systems such as tablets, capsules, liquids, semi-solids, intravenous fluids, metered dose inhalers, dry powder inhalers, sterile ophthalmic drops, insulins, prefilled syringes,...

Investegate announcements from Medica Group PLC, Dr. Robert Lavis appointed Group Medical Director